[HTML][HTML] Glycerophosphodiesterase GDE2 promotes neuroblastoma differentiation through glypican release and is a marker of clinical outcome
E Matas-Rico, M van Veen, D Leyton-Puig… - Cancer cell, 2016 - cell.com
Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal
differentiation. A better understanding of neuroblastoma differentiation is essential for …
differentiation. A better understanding of neuroblastoma differentiation is essential for …
[PDF][PDF] Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome
E Matas-Rico, M van Veen, D Leyton-Puig… - Cancer Cell, 2016 - cyberleninka.org
Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal
differentiation. A better understanding of neuroblastoma differentiation is essential for …
differentiation. A better understanding of neuroblastoma differentiation is essential for …
[PDF][PDF] Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and is a Marker of Clinical Outcome
E Matas-Rico, M van Veen… - GDE …, 2018 - scholarlypublications …
Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal
differentiation. A better understanding of neuroblastoma differentiation is essential for …
differentiation. A better understanding of neuroblastoma differentiation is essential for …
Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome
E Matas-Rico, M van Veen… - Cancer …, 2016 - researchinformation.amsterdamumc …
Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal
differentiation. A better understanding of neuroblastoma differentiation is essential for …
differentiation. A better understanding of neuroblastoma differentiation is essential for …
Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome
E Matas-Rico, M van Veen, D Leyton-Puig… - Cancer …, 2016 - pubmed.ncbi.nlm.nih.gov
Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal
differentiation. A better understanding of neuroblastoma differentiation is essential for …
differentiation. A better understanding of neuroblastoma differentiation is essential for …
[HTML][HTML] Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome
E Matas-Rico, M van Veen, D Leyton-Puig… - Cancer Cell, 2016 - Elsevier
Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal
differentiation. A better understanding of neuroblastoma differentiation is essential for …
differentiation. A better understanding of neuroblastoma differentiation is essential for …
Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome
E Matas-Rico, M van Veen, D Leyton-Puig… - Cancer Cell, 2016 - cell.com
(Cancer Cell 30, 548–562; October 10, 2016) During the production process, the authors
inadvertently replaced the Supplemental Information file with a version that was missing the …
inadvertently replaced the Supplemental Information file with a version that was missing the …
Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome.
E Matas-Rico, M van Veen, D Leyton-Puig… - Cancer Cell, 2016 - europepmc.org
Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal
differentiation. A better understanding of neuroblastoma differentiation is essential for …
differentiation. A better understanding of neuroblastoma differentiation is essential for …
[PDF][PDF] Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome
E Matas-Rico, M van Veen, D Leyton-Puig… - Cancer Cell, 2016 - core.ac.uk
Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal
differentiation. A better understanding of neuroblastoma differentiation is essential for …
differentiation. A better understanding of neuroblastoma differentiation is essential for …
Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome
E Matas-Rico, M van Veen, D Leyton-Puig… - Cancer Cell, 2016 - infona.pl
Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal
differentiation. A better understanding of neuroblastoma differentiation is essential for …
differentiation. A better understanding of neuroblastoma differentiation is essential for …